Plain-English translation of NCT07429006 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-time-in-humans trial testing a new medication called given through an IV. Researchers want to understand how the medication works in the body, what side effects it might cause, and what dose is safe. The study involves two stages: first testing a single dose at different strength levels, then testing repeated doses.
Before any new medication can be tested in patients with a disease, researchers must first confirm it is safe in healthy people. This early-stage trial is designed to establish the safety foundation for this treatment.
You likely qualify if…
You likely don't qualify if…
You will receive either the new medication or a placebo (fake medication) as a single IV injection or through multiple IV injections over time, depending on which stage of the study you join. You'll have blood tests, heart rhythm tests (ECG), and physical exams before, during, and after treatment. The trial requires you to stay confined at a clinic for observation periods and return for follow-up visits to monitor how you tolerate the medication.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
New Zealand